144 related articles for article (PubMed ID: 18035834)
1. Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells.
Meegan MJ; Barrett I; Zimmermann J; Knox AJ; Zisterer DM; Lloyd DG
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):655-66. PubMed ID: 18035834
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.
Lloyd DG; Smith HM; O'Sullivan T; Zisterer DM; Meegan MJ
Med Chem; 2005 Jul; 1(4):335-53. PubMed ID: 16789891
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators.
Barrett I; Meegan MJ; Hughes RB; Carr M; Knox AJ; Artemenko N; Golfis G; Zisterer DM; Lloyd DG
Bioorg Med Chem; 2008 Nov; 16(21):9554-73. PubMed ID: 18835176
[TBL] [Abstract][Full Text] [Related]
4. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.
Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ
J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159
[TBL] [Abstract][Full Text] [Related]
5. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactam type molecular scaffolds for antiproliferative activity: synthesis and cytotoxic effects in breast cancer cells.
Meegan MJ; Carr M; Knox AJ; Zisterer DM; Lloyd DG
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):668-85. PubMed ID: 18821256
[TBL] [Abstract][Full Text] [Related]
7. Design and Synthesis of Some Novel Estrogen Receptor Modulators as Anti-Breast Cancer Agents: In Vitro & In Vivo Screening, Docking Analysis.
Dube PN; Mokale SN
Anticancer Agents Med Chem; 2016; 16(11):1461-1467. PubMed ID: 26863879
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists.
Lloyd DG; Smith HM; O'Sullivan T; Knox AS; Zisterer DM; Meegan MJ
Med Chem; 2006 Mar; 2(2):147-68. PubMed ID: 16787364
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chains.
Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
Bioorg Med Chem Lett; 2016 Apr; 26(8):1963-9. PubMed ID: 26972118
[TBL] [Abstract][Full Text] [Related]
10. Flexible estrogen receptor modulators: synthesis, biochemistry and molecular modeling studies for 3-benzyl-4,6-diarylhex-3-ene and 3,4,6-triarylhex-3-ene derivatives.
Smith HM; Knox AJ; Zisterer DM; Lloyd DG; Meegan MJ
Med Chem; 2007 Mar; 3(2):135-55. PubMed ID: 17348852
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators.
Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of doxorubicin-formaldehyde conjugates targeted to breast cancer cells.
Burke PJ; Koch TH
J Med Chem; 2004 Feb; 47(5):1193-206. PubMed ID: 14971899
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
[TBL] [Abstract][Full Text] [Related]
15. Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.
Kelly PM; Keely NO; Bright SA; Yassin B; Ana G; Fayne D; Zisterer DM; Meegan MJ
Molecules; 2017 Aug; 22(9):. PubMed ID: 28858267
[TBL] [Abstract][Full Text] [Related]
16. Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells.
Meegan MJ; Hughes RB; Lloyd DG; Williams DC; Zisterer DM
J Med Chem; 2001 Mar; 44(7):1072-84. PubMed ID: 11297454
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
18. Aerobic iron-based cross-dehydrogenative coupling enables efficient diversity-oriented synthesis of coumestrol-based selective estrogen receptor modulators.
Kshirsagar UA; Parnes R; Goldshtein H; Ofir R; Zarivach R; Pappo D
Chemistry; 2013 Sep; 19(40):13575-83. PubMed ID: 23946113
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids.
Mendoza-Sanchez R; Cotnoir-White D; Kulpa J; Jutras I; Pottel J; Moitessier N; Mader S; Gleason JL
Bioorg Med Chem; 2015 Dec; 23(24):7597-606. PubMed ID: 26613635
[TBL] [Abstract][Full Text] [Related]
20. Construction of benzofuranone library via a metal-free, one-pot intermolecular condensation, and their application as efficient estrogen receptor β modulators.
Peng X; Hu Z; Zhang J; Ning W; Zhang S; Dong C; Shi X; Zhou HB
Chem Commun (Camb); 2019 Dec; 55(97):14570-14573. PubMed ID: 31660550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]